Publication Details

Pubmed28068319
Title: FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Year: 2017
DOI: https://doi.org/10.1038/onc.2016.479
First Author: Zhou
Experimental setup: affinity chromatography technology (Biogrid)
Throughput: Low Throughput (Biogrid)

Interactions

1 interaction
InteractorPartnerSourcesLink
KLF4_HUMANFBX32_HUMANBioGRIDdetails